1581 related articles for article (PubMed ID: 32358837)
1. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.
Middleton P; Shepherd E; Gomersall JC
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001689. PubMed ID: 33779986
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
Lin PT; Wang SH; Chi CC
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
[TBL] [Abstract][Full Text] [Related]
6. Interventions for preventing thrombosis in solid organ transplant recipients.
Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
[TBL] [Abstract][Full Text] [Related]
7. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.
Empson M; Lassere M; Craig J; Scott J
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002859. PubMed ID: 15846641
[TBL] [Abstract][Full Text] [Related]
8. Progestogens for preventing miscarriage: a network meta-analysis.
Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
[TBL] [Abstract][Full Text] [Related]
11. Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.
Wojcieszek AM; Shepherd E; Middleton P; Lassi ZS; Wilson T; Murphy MM; Heazell AE; Ellwood DA; Silver RM; Flenady V
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012203. PubMed ID: 30556599
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation for women during pregnancy.
Palacios C; Kostiuk LK; Peña-Rosas JP
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD008873. PubMed ID: 31348529
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet agents for preventing pre-eclampsia and its complications.
Duley L; Meher S; Hunter KE; Seidler AL; Askie LM
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684684
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?
Hamulyák EN; Scheres LJJ; Goddijn M; Middeldorp S
J Thromb Haemost; 2021 May; 19(5):1174-1185. PubMed ID: 33687789
[TBL] [Abstract][Full Text] [Related]
18. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acid addition during pregnancy.
Middleton P; Gomersall JC; Gould JF; Shepherd E; Olsen SF; Makrides M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003402. PubMed ID: 30480773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
